Delivery Order SPE2DB20D2014-SPE2DB25FA30W

Award Date 11/8/24
Potential Completion Date 11/12/24
Potential Value $5.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,813.77 firm fixed-price delivery order is for the supply of XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of January 23, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,614.21, is for the delivery of XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product. The contract type is Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of June 11, 2024. Amerisourcebergen holds a significant $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,566.96 firm fixed-price delivery order is for XELJANZ XR 11 MG TABLET UU 30S, a specialty medication. The contract has a completion date of February 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,370.14 Firm Fixed Price Delivery Order contract is for the supply of XELJANZ XR 11 MG TABLET medication. The contract has an ultimate completion date of February 20, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,947.26 fixed-price delivery order is for XELJANZ XR 11 MG TABLET UU 30S, with a completion date of November 18, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $31,807.89 fixed-price delivery order is for the supply of XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of February 10, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,038.22 Firm Fixed Price Delivery Order contract is for the supply of XELJANZ XR 11 MG TABLET medication. The contract has an ultimate completion date of October 31, 2023 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,535.10, is a delivery order for the supply of XELJANZ XR 11 MG TABLET UU 30S. The contract is a firm fixed-price agreement with an ultimate completion date of April 2, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award from the Defense Logistics Agency (DLA) is a Delivery Order valued at $6,758.90 with a firm fixed price. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of XELJANZ XR 11 MG TABLET UU 30S, a pharmaceutical product, with a period of performance through March 21, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is a $2,549.80 firm fixed price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania. Amerisourcebergen, a for-profit pharmaceutical sourcing and distribution company, is the prime contractor providing XELJANZ XR 11 MG TABLETS with a completion date of January 30, 2024. This delivery order is part of a larger indefinite delivery contract...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FA30W
    Delivery Order

This federal contract award, valued at $5,206.27, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the pharmaceutical product "XELJANZ XR 11 MG TABLET UU 30S" and has a firm fixed price. The ultimate completion date for this contract is November 12, 2024.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. Additionally, the company maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

This contract award was not designated with a set-aside requirement, indicating open competition. The Place of Performance is Conshohocken, PA 19428, USA.

Generated 5/20/25, 2:18 PM